Pharma M&A Booming In First Eight Months Of The Year
This article was originally published in The Pink Sheet Daily
Executive Summary
The year 2015 could give 2014 a run for the money in terms of biopharma M&A deal value. From January through August, 18 deals were signed with an upfront value of more than $1bn, representing a total upfront value of $133bn.